<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37533859</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>COVID, complement, and the brain.</ArticleTitle><Pagination><StartPage>1216457</StartPage><MedlinePgn>1216457</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1216457</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1216457</ELocationID><Abstract><AbstractText>The brains of COVID-19 patients are affected by the SARS-CoV-2 virus, and these effects may contribute to several COVID-19 sequelae, including cognitive dysfunction (termed "long COVID" by some researchers). Recent advances concerning the role of neuroinflammation and the consequences for brain function are reviewed in this manuscript. Studies have shown that respiratory SARS-CoV-2 infection in mice and humans is associated with selective microglial reactivity in the white matter, persistently impaired hippocampal neurogenesis, a decrease in the number of oligodendrocytes, and myelin loss. Brain MRI studies have revealed a greater reduction in grey matter thickness in the orbitofrontal cortex and parahippocampal gyrus, associated with a greater reduction in global brain size, in those with SARS-CoV-2 and a greater cognitive decline. COVID-19 can directly infect endothelial cells of the brain, potentially promoting clot formation and stroke; complement C3 seems to play a major role in this process. As compared to controls, the brain tissue of patients who died from COVID-19 have shown a significant increase in the extravasation of fibrinogen, indicating leakage in the blood-brain barrier; furthermore, recent studies have documented the presence of IgG, IgM, C1q, C4d, and C5b-9 deposits in the brain tissue of COVID-19 patients. These data suggest an activation of the classical complement pathway and an immune-mediated injury to the endothelial cells. These findings implicate both the classical and alternative complement pathways, and they indicate that C3b and the C5b-9 terminal complement complex (membrane attack complex, MAC) are acting in concert with neuroinflammatory and immune factors to contribute to the neurological sequelae seen in patients with COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Vlaicu, Tatomir, Cuevas, Rus and Rus.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vlaicu</LastName><ForeName>Sonia I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Medical Clinic Nr. 1, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatomir</LastName><ForeName>Alexandru</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuevas</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rus</LastName><ForeName>Violeta</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Maryland, School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rus</LastName><ForeName>Horea</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Service, Baltimore Veterans Administration Medical Center, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS042011</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015938">Complement Membrane Attack Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015938" MajorTopicYN="Y">Complement Membrane Attack Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C5b-9</Keyword><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">complement system</Keyword><Keyword MajorTopicYN="N">endothelial cells</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>4</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37533859</ArticleId><ArticleId IdType="pmc">PMC10391634</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1216457</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron (2022) 110(21):3484&#x2013;96. doi:&#xa0;10.1016/j.neuron.2022.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrottelli A, Sansone N, Giordano GM, Caporusso E, Giuliani L, Melillo A, et al. . Cognitive impairment after post-acute COVID-19 infection: a systematic review of the literature. J Pers Med (2022) 12(12):2070. doi:&#xa0;10.3390/jpm12122070</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12122070</ArticleId><ArticleId IdType="pmc">PMC9781311</ArticleId><ArticleId IdType="pubmed">36556290</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in long covid-19. N Engl J Med (2022) 387(19):1813&#x2013;5. doi:&#xa0;10.1056/NEJMcibr2210069</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med (2022) 28(11):2406&#x2013;15. doi:&#xa0;10.1038/s41591-022-02001-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte E. Untangling genetic risk factors of long COVID: work of the international COVID-10 host genetics initiative. Eur Neuropsychopharmacol (2022) 63:e82. doi: 10.1016/j.euroneuro.2022.07.155</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2022.07.155</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappadona C, Rimoldi V, Paraboschi EM, Asselta R. Genetic susceptibility to severe COVID-19. Infection Genet Evol (2023) 110:105426. doi:&#xa0;10.1016/jmeegid.2023;1054026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jmeegid.2023;1054026</ArticleId><ArticleId IdType="pmc">PMC10022467</ArticleId><ArticleId IdType="pubmed">36934789</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee M-H, Wood J, et al. . et al: mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell (2022) 185(14):2452&#x2013;2468.e2416. doi:&#xa0;10.1016/j.cell.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontes-Dantas FL, Fernandes GG, Gutman EG, De Lima EV, Antonio LS, Hammerle MB, et al. . : SARS-CoV-2 spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep (2023) 42(3):112189. doi:&#xa0;10.1016/j.celrep.2023.112189</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112189</ArticleId><ArticleId IdType="pmc">PMC9935273</ArticleId><ArticleId IdType="pubmed">36857178</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchetti G, Agosta F, Canu E, Basaia S, Barbieri A, Cardamone R, et al. . : cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol (2022) 269(7):3400&#x2013;12. doi:&#xa0;10.1007/s00415-022-11047-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11047-5</ArticleId><ArticleId IdType="pmc">PMC8898558</ArticleId><ArticleId IdType="pubmed">35249144</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . : SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature (2022) 604(7907):697&#x2013;707. doi:&#xa0;10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. . 18F-FDG brain PET hypometabolism in patients with long COVID. EJNMMI (2021) 48(9):2823&#x2013;33. doi:&#xa0;10.1007/s00259-021-05215-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Aj&#x10d;evi&#x107; M, Iscra K, Furlanis G, Michelutti M, Miladinovi&#x107; A, Buoite Stella A, et al. . Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci Rep (2023) 13(1):5808. doi:&#xa0;10.1038/s41598-023-32275-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32275-3</ArticleId><ArticleId IdType="pmc">PMC10086005</ArticleId><ArticleId IdType="pubmed">37037833</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter MM, Martins TA, Kulsvehagen L, P&#xf6;ssnecker E, Duchemin W, Hogan S, et al. . : severe neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat Commun (2022) 13(1):6777. doi:&#xa0;10.1038/s41467-022-34068-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. . : dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature (2021) 595(7868):565&#x2013;71. doi:&#xa0;10.1038/s41586-021-04080-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04080-3</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, Sali&#xe9; H, Tanevski J, Killmer S, Lago MS, Schlaak AE, et al. . : deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-t-cell interactions. Immunity (2021) 54(7):1594&#x2013;610. doi:&#xa0;10.1016/j.immuni.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko N, Satta S, Komuro Y, Muthukrishnan SD, Kakarla V, Guo L, et al. . : flow-mediated susceptibility and molecular response of cerebral endothelia to SARS-CoV-2 infection. Stroke (2021) 52(1):260&#x2013;70. doi: 10.1161/STROKEAHA.120.032764</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.032764</ArticleId><ArticleId IdType="pmc">PMC7769899</ArticleId><ArticleId IdType="pubmed">33161843</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegla CA, Cudrici C, Patel S, 3rd TR, Rus V, Niculescu F, et al. . : membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res (2011) 51(1):45&#x2013;60. doi:&#xa0;10.1007/s12026-011-8239-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-011-8239-5</ArticleId><ArticleId IdType="pmc">PMC3732183</ArticleId><ArticleId IdType="pubmed">21850539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Zou Q, Ding X, Shi D, Zhu X, Hu W, et al. . Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain. J Neuroinflamm (2016) 13(1):23. doi:&#xa0;10.1186/s12974-016-0485-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0485-y</ArticleId><ArticleId IdType="pmc">PMC4731990</ArticleId><ArticleId IdType="pubmed">26822321</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocco J, Mack WJ, Ducruet AF, Sosunov SA, Sughrue ME, Hassid BG, et al. . : complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res (2006) 99(2):209&#x2013;17. doi:&#xa0;10.1161/01.RES.0000232544.90675.42</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000232544.90675.42</ArticleId><ArticleId IdType="pubmed">16778128</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi FM, Harvey D, Altendahl M, Brathaban N, Fernandes N, Casaletto KB, et al. . : elevated complement mediator levels in endothelial-derived plasma exosomes implicate endothelial innate inflammation in diminished brain function of aging humans. Sci Rep (2021) 11(1):16198. doi:&#xa0;10.1038/s41598-021-91759-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91759-2</ArticleId><ArticleId IdType="pmc">PMC8355229</ArticleId><ArticleId IdType="pubmed">34376699</ArticleId></ArticleIdList></Reference><Reference><Citation>Fosbrink M, Niculescu F, Rus H. The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription. Immunol Res (2005) 31(1):37&#x2013;46. doi:&#xa0;10.1385/IR:31:1:37</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/IR:31:1:37</ArticleId><ArticleId IdType="pubmed">15591621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J, Lampe J, M&#xfc;ller-Fielitz H, Schuster R, Zille M, M&#xfc;ller K, et al. . : the SARS-CoV-2 main protease mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci (2021) 24(11):1522&#x2013;33. doi:&#xa0;10.1038/s41593-021-00926-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00926-1</ArticleId><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M-H, Perl DP, Nair G, Li W, Maric D, Murray H, et al. . : microvascular injury in the brains of patients with covid-19. N Engl J Med (2020) 384(5):481&#x2013;3. doi:&#xa0;10.1056/NEJMc2033369</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D, et al. . : neurovascular injury with complement activation and inflammation in COVID-19. Brain (2022) 145(7):2555&#x2013;68. doi:&#xa0;10.1093/brain/awac151</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlaicu SI, Tatomir A, Boodhoo D, Ito T, Fosbrink M, Cudrici C, et al. . : RGC-32 is expressed in the human atherosclerotic arterial wall: role in C5b-9-induced cell proliferation and migration. Exp Mol Pathol (2016) 101(2):221&#x2013;30. doi:&#xa0;10.1016/j.yexmp.2016.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2016.09.004</ArticleId><ArticleId IdType="pubmed">27619159</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadi S, Holzknecht RA, Patte CP, Stern DM, Platt JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med (1995) 182(6):1807&#x2013;14. doi: 10.1084/jem.182.6.1807</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.182.6.1807</ArticleId><ArticleId IdType="pmc">PMC2192255</ArticleId><ArticleId IdType="pubmed">7500026</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadi S, Holzknecht RA, Patte CP, Platt JL. Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1alpha. Circulation (2000) 101(15):1867&#x2013;73. doi:&#xa0;10.1161/01.CIR.101.15.1867</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.101.15.1867</ArticleId><ArticleId IdType="pubmed">10769290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilgore KS, Schmid E, Shanley TP, Flory CM, Maheswari V, Tramontini NL, et al. . Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa b activation. Am J Pathol (1997) 150(6):2019&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1858311</ArticleId><ArticleId IdType="pubmed">9176395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of e-selectin and ICAM-1. J Immunol (1995) 155(3):1434&#x2013;41. doi: 10.4049/jimmunol.155.3.1434</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.155.3.1434</ArticleId><ArticleId IdType="pubmed">7543521</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzaquen LR, Nicholson-Weller A, Halperin JA. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med (1994) 179(3):985&#x2013;92. doi: 10.1084/jem.179.3.985</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.179.3.985</ArticleId><ArticleId IdType="pmc">PMC2191420</ArticleId><ArticleId IdType="pubmed">8113689</ArticleId></ArticleIdList></Reference><Reference><Citation>Fosbrink M, Niculescu F, Rus V, Shin ML, Rus H. C5b-9-induced endothelial cell proliferation and migration are dependent on akt inactivation of forkhead transcription factor FOXO1. J Biol Chem (2006) 281(28):19009&#x2013;18. doi:&#xa0;10.1074/jbc.M602055200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M602055200</ArticleId><ArticleId IdType="pubmed">16670089</ArticleId></ArticleIdList></Reference><Reference><Citation>Fosbrink M, Cudrici C, Tegla CA, Soloviova K, Ito T, Vlaicu S, et al. . Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells. Exp Mol Pathol (2009) 86(2):87&#x2013;94. doi:&#xa0;10.1016/j.yexmp.2008.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2008.12.005</ArticleId><ArticleId IdType="pmc">PMC2699899</ArticleId><ArticleId IdType="pubmed">19162005</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzali B, Noris M, Lambrecht BN, Kemper C. The state of complement in COVID-19. Nat Rev Immunol (2022) 22(2):77&#x2013;84. doi:&#xa0;10.1038/s41577-021-00665-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00665-1</ArticleId><ArticleId IdType="pmc">PMC8672651</ArticleId><ArticleId IdType="pubmed">34912108</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>